Intervacc AB
Develops recombinant protein-based vaccines for animal health.
IVACC | ST
Overview
Corporate Details
- ISIN(s):
- SE0009607252 (+1 more)
- LEI:
- 549300OICIVZBBZRNZ64
- Country:
- Sweden
- Address:
- Västertorpsvägen 135B, 129 44 Hägersten
- Website:
- https://intervacc.se/
- Sector:
- Manufacturing
Description
Intervacc AB is a biotechnology company focused on developing a new generation of vaccines for animal health. The company's technology platform utilizes fusions of recombinant proteins, a modern approach that avoids attenuated live strains, based on research from the Karolinska Institutet and the Swedish University of Agricultural Sciences. Its lead commercial product is Strangvac®, a vaccine for horses against strangles caused by Streptococcus equi. The development pipeline includes vaccine candidates targeting significant bacterial diseases, such as Streptococcus suis infections in pigs and Staphylococcus aureus-induced mastitis in dairy cows. Intervacc's mission is to improve animal health and welfare while contributing to the reduction of antibiotic use and combating antimicrobial resistance. The company manages sales and distribution through its subsidiary, Nordvacc.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Intervacc AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Intervacc AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Intervacc AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-26 | Lennart Johansson | Other | Other | 813,474 | 691,452.90 SEK |
| 2025-02-21 | Lennart Johansson | Other | Other | 324,156 | 275,532.60 SEK |
Peer Companies
